EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Treatment of Acute Liver Injury through Selective Tropism of High Mobility Group Box 1 Gene-Silenced Large Peritoneal Macrophages

Dhaval Oza, Fernando Ivich, Kirsten Deprey, Kelsey Bittner, Keith Bailey, Sarah Goldman, Mikyung Yu, Mark Niedre, Ho-Chou Tu, Mansoor M Amiji iD

ACS Nano · 2025

DOI: 10.1021/acsnano.4c18345 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, 2025. Verfasst von Dhaval Oza und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, Northeastern University, 360 Huntington Avenue, Boston, Massac…. Hauptthemen laut MEDLINE: HMGB1 Protein, RNA, Small Interfering, Macrophages, Peritoneal, Gene Silencing. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Northeastern University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High Resolution Image Download MS PowerPoint Slide Tissue-resident macrophages (TRMs) are attractive cells to therapeutically deliver oligonucleotide and other gene-expression modifying modalities to treat a wide array of diseases ranging from inflammatory to autoimmune, and even cancer. Here, we focus on TRMs located inside the peritoneal cavity lining the abdomen that selectively express a transcription factor GATA6 called large peritoneal macrophages (GLPMs) and successfully demonstrate functional GLPM-selective delivery of a Cy5-fluorophore-labeled siRNA encapsulated in C12–200 cationic-lipidoid-based nanoparticles (siRNA-Cy5 (C12–200)). Despite being TRMs, GLPMs possess a specific migratory ability to peritoneally located liver tissue upon injury incited by acetaminophen (APAP) overdose in mice. A rapid, liver injury-driven tropism of GLPMs carrying siRNA-Cy5 (C12–200) was seen via systemic circulation, which was elegantly demonstrated by using a noninvasive live-cell tracking technique called diffuse in vivo flow cytometry (DiFC). Finally, RNAi-mediated silencing of a well-known pro-inflammatory damage-associated molecular pattern (DAMP) High Mobility Group Box-1 (HMGB1) gene in GLPMs led to the mitigation of liver injury and inflammation via prevention of GLPM modulation to a pro-inflammatory state, which further translated into significant protection from APAP-driven liver injury and a reduction in liver circulating pro-inflammatory cytokines owing to a muted inflammatory response to acute liver injury. Moreover, silencing HMGB1 by a GalNAc-conjugated hepatocyte-targeting siRNA did not reciprocate the findings, further solidifying our results. Together, our data suggested that GLPMs act as delivery carriers by rapidly bringing lipid nanoparticle-encapsulated RNAi modalities to the injured liver and have emerged as a therapeutically viable strategy to address inflammatory diseases, especially those that are more acute in nature.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HMGB1 ProteinRNA, Small InterferingMacrophages, PeritonealGene SilencingChemical and Drug Induced Liver InjuryAnimalsMiceNanoparticlesMice, Inbred C57BLLiverAcetaminophenMale

Stichwörter der Autor:innen

GATA6-expressing large peritoneal macrophagesHigh Mobility Group Box-1acute liver injurydiffuse in vivo flow cytometrylipid nanoparticlessmall interfering RNAs

Substanzen

HMGB1 ProteinRNA, Small InterferingAcetaminophen

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, Northeastern University, 360 Huntington Avenue, Boston, Massachusetts 02115, United States.
  • Alnylam Pharmaceuticals, 675 West Kendall Street, Cambridge, Massachusetts 02142, United States.
  • Department of Bioengineering, College of Engineering, Northeastern University, 360 Huntington Avenue, Boston, Massachusetts 02115, United States.
  • Department of Chemical Engineering, College of Engineering, Northeastern University, 360 Huntington Avenue, Boston, Massachusetts 02115, United States.

ORCID-Profile: Mansoor M Amiji

Förderung

  • Northeastern University

Zitieren

APA

Oza, D., Ivich, F., Deprey, K., Bittner, K., Bailey, K., Goldman, S., Yu, M., Niedre, M., Tu, H. C., & Amiji, M. M. (2025). Treatment of Acute Liver Injury through Selective Tropism of High Mobility Group Box 1 Gene-Silenced Large Peritoneal Macrophages. ACS Nano. https://doi.org/10.1021/acsnano.4c18345

Vancouver

Oza D, Ivich F, Deprey K, Bittner K, Bailey K, Goldman S, et al. Treatment of Acute Liver Injury through Selective Tropism of High Mobility Group Box 1 Gene-Silenced Large Peritoneal Macrophages. ACS Nano. 2025. doi:10.1021/acsnano.4c18345

BibTeX
@article{Oza2025,
  author = {Oza, Dhaval and Ivich, Fernando and Deprey, Kirsten and Bittner, Kelsey and Bailey, Keith and Goldman, Sarah and Yu, Mikyung and Niedre, Mark and Tu, Ho-Chou and Amiji, Mansoor M},
  title = {Treatment of Acute Liver Injury through Selective Tropism of High Mobility Group Box 1 Gene-Silenced Large Peritoneal Macrophages},
  journal = {ACS Nano},
  year = {2025},
  doi = {10.1021/acsnano.4c18345}
}
Kostenlos starten →